UniProt ID | BAX_HUMAN | |
---|---|---|
UniProt AC | Q07812 | |
Protein Name | Apoptosis regulator BAX | |
Gene Name | BAX | |
Organism | Homo sapiens (Human). | |
Sequence Length | 192 | |
Subcellular Localization |
Isoform Alpha: Mitochondrion membrane Single-pass membrane protein. Cytoplasm . Colocalizes with 14-3-3 proteins in the cytoplasm. Under stress conditions, undergoes a conformation change that causes release from JNK-phosphorylated 14-3-3 proteins a |
|
Protein Description | Plays a role in the mitochondrial apoptotic process. Under normal conditions, BAX is largely cytosolic via constant retrotranslocation from mitochondria to the cytosol mediated by BCL2L1/Bcl-xL, which avoids accumulation of toxic BAX levels at the mitochondrial outer membrane (MOM). [PubMed: 21458670 Under stress conditions, undergoes a conformation change that causes translocation to the mitochondrion membrane, leading to the release of cytochrome c that then triggers apoptosis. Promotes activation of CASP3, and thereby apoptosis.] | |
Protein Sequence | MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSECLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALCTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQTVTIFVAGVLTASLTIWKKMG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDGSGEQP -------CCCCCCCC | 13.70 | 25944712 | |
4 | Phosphorylation | ----MDGSGEQPRGG ----CCCCCCCCCCC | 34.59 | 29514088 | |
9 | Methylation | DGSGEQPRGGGPTSS CCCCCCCCCCCCCCH | 56.96 | - | |
14 | Phosphorylation | QPRGGGPTSSEQIMK CCCCCCCCCHHHHHH | 48.43 | 21406692 | |
15 | Phosphorylation | PRGGGPTSSEQIMKT CCCCCCCCHHHHHHH | 34.70 | 28857561 | |
16 | Phosphorylation | RGGGPTSSEQIMKTG CCCCCCCHHHHHHHH | 35.68 | 21406692 | |
20 | Sulfoxidation | PTSSEQIMKTGALLL CCCHHHHHHHHHHHH | 2.96 | 30846556 | |
21 (in isoform 8) | Ubiquitination | - | 45.49 | 21890473 | |
21 (in isoform 5) | Ubiquitination | - | 45.49 | 21890473 | |
21 | Ubiquitination | TSSEQIMKTGALLLQ CCHHHHHHHHHHHHH | 45.49 | 21890473 | |
21 (in isoform 1) | Ubiquitination | - | 45.49 | 21890473 | |
21 (in isoform 2) | Ubiquitination | - | 45.49 | 21890473 | |
22 | Phosphorylation | SSEQIMKTGALLLQG CHHHHHHHHHHHHHH | 15.42 | 21712546 | |
38 (in isoform 7) | Ubiquitination | - | 8.71 | 21906983 | |
38 | Sulfoxidation | IQDRAGRMGGEAPEL HHHHCCCCCCCCCHH | 8.71 | 21406390 | |
57 (in isoform 1) | Ubiquitination | - | 49.58 | 21890473 | |
57 (in isoform 2) | Ubiquitination | - | 49.58 | 21890473 | |
57 | Ubiquitination | VPQDASTKKLSECLK CCCCCCHHHHHHHHH | 49.58 | 2190698 | |
57 (in isoform 8) | Ubiquitination | - | 49.58 | 21890473 | |
57 (in isoform 5) | Ubiquitination | - | 49.58 | 21890473 | |
58 | Ubiquitination | PQDASTKKLSECLKR CCCCCHHHHHHHHHH | 58.28 | - | |
60 | Phosphorylation | DASTKKLSECLKRIG CCCHHHHHHHHHHHH | 34.83 | 17911107 | |
64 | Ubiquitination | KKLSECLKRIGDELD HHHHHHHHHHHHHHH | 54.34 | - | |
72 | Phosphorylation | RIGDELDSNMELQRM HHHHHHHHHHHHHHH | 51.18 | 25338102 | |
74 | Sulfoxidation | GDELDSNMELQRMIA HHHHHHHHHHHHHHH | 6.69 | 30846556 | |
79 | Sulfoxidation | SNMELQRMIAAVDTD HHHHHHHHHHHHCCC | 1.25 | 21406390 | |
85 | Phosphorylation | RMIAAVDTDSPREVF HHHHHHCCCCHHHHH | 31.60 | 20068231 | |
87 | Phosphorylation | IAAVDTDSPREVFFR HHHHCCCCHHHHHHH | 28.13 | 20068231 | |
123 | Ubiquitination | FASKLVLKALCTKVP HHHHHHHHHHHCCHH | 31.65 | - | |
126 | S-palmitoylation | KLVLKALCTKVPELI HHHHHHHHCCHHHHH | 4.07 | 24525733 | |
135 | Phosphorylation | KVPELIRTIMGWTLD CHHHHHHHHHHHHHH | 14.34 | 19194518 | |
140 | Phosphorylation | IRTIMGWTLDFLRER HHHHHHHHHHHHHHH | 15.66 | 19194518 | |
145 (in isoform 5) | Phosphorylation | - | 27.29 | 22210691 | |
148 (in isoform 5) | Phosphorylation | - | 4.43 | 22210691 | |
163 (in isoform 2) | Ubiquitination | - | 24.37 | - | |
163 | Phosphorylation | GGWDGLLSYFGTPTW CCCCCHHHHHCCCCC | 24.37 | 15525785 | |
167 | Phosphorylation | GLLSYFGTPTWQTVT CHHHHHCCCCCCEEH | 13.98 | 16709574 | |
172 | Phosphorylation | FGTPTWQTVTIFVAG HCCCCCCEEHHHHHH | 15.92 | - | |
174 | Phosphorylation | TPTWQTVTIFVAGVL CCCCCEEHHHHHHHH | 16.46 | - | |
184 | Phosphorylation | VAGVLTASLTIWKKM HHHHHHHHHHHHHHC | 22.32 | 16679323 | |
186 | Phosphorylation | GVLTASLTIWKKMG- HHHHHHHHHHHHCC- | 23.46 | - | |
207 (in isoform 2) | Phosphorylation | - | 24719451 | ||
215 (in isoform 2) | Phosphorylation | - | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
163 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
184 | S | Phosphorylation | Kinase | PRKCZ | Q05513 | GPS |
184 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF144B | Q7Z419 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:22460798 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BAX_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BAX_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00020 | Colorectal cancer | |||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. |